| Description |
S07-2010 is a potent pan-AKR1C (aldo-keto reductase family 1 member C) inhibitor, with IC50 values of 0.19, 0.36, 0.47, and 0.73 μM for AKR1C3, AKR1C4, AKR1C1 and AKR1C2, respectively. S07-2010 induces apoptosis in A549/DDP cells. S07-2010 strengthens the cytotoxicity of chemotherapeutic agents in drug-resistant cells. S07-2010 significantly inhibits the proliferation of drug-resistant cells[1].
|
| Related Catalog |
|
| Target |
IC50: 0.19 ± 0.08 μM (AKR1C3), 0.36 ± 0.15 μM (AKR1C4), 0.47 ± 0.16 μM (AKR1C1), 0.73 ± 0.35 μM (AKR1C2)[1]
|
| In Vitro |
S07-2010 (0-25 μM, 48h) exhibits obvious cytotoxicity on MCF-7/DOX and A549/DDP, with IC50 values of 127.5 and 5.51 μM, respectively[1].
|
| References |
[1]. Siyu He, et al. Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance. ACS Med. Chem. Lett. 2022.
|
